Breaking News
0

Trevena Inc (TRVN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Trevena Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.53 -0.02    -2.89%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
0.56
+0.03
+4.99%
17:35:11 - Real-time Data
Type: Equity
Market: United States
ISIN: US89532E1091 
CUSIP: 89532E109
  • Volume: 538,973
  • Bid/Ask: 0.49 / 0.59
  • Day's Range: 0.53 - 0.57
Trevena Inc 0.53 -0.02 -2.89%

TRVN Overview

 
Information about the Trevena Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.55
Day's Range0.53 - 0.57
Revenue5.5M
Open0.56
52 wk Range0.38 - 3.58
EPS - 0.57
Volume538,973
Market Cap45.05M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)2,085,080
P/E RatioN/A
Beta1.19
1-Year Change - 69.71%
Shares Outstanding82,323,413
Next Earnings DateMar 05, 2019
What is your sentiment on Trevena Inc?
or
Market is currently closed. Voting is open during market hours.

Trevena Inc News


Trevena Inc Analysis


Harry Boxer
4 Stocks To Watch: BHC, CGC, COLL, CRC By Harry Boxer - Oct 04, 2018

Bausch Health Companies Inc. (NYSE:BHC) swing trade broke out above its June high on Wednesday, gaining 1.06, or 4%, to 28.32, on 9.7 million shares. That’s decent volume for...

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Technical Indicators Sell Strong Sell Strong Sell Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bullish 5H Current
Completed Patterns
Three Black Crows 1M 1 Dec 18
Engulfing Bearish 1W 1 Jan 13, 2019
Evening Doji Star 1W 1 Jan 13, 2019

Trevena Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 0.53 0.49 0.59 538,973 -2.89% USD 15:59:59  
  Berlin 0.451 0.000 0.000 0 -0.44% EUR 02:02:00  
  Stuttgart 0.479 0.000 0.000 0 +3.23% EUR 00:00:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 153.30 156.73 152.62 -3.52 -2.24% 30.39M 15:59:59  
  Alphabet A 1,078.63 1,098.97 1,070.89 -28.67 -2.59% 1.98M 15:59:59  
  Facebook 147.57 151.53 146.37 -2.47 -1.65% 22.38M 15:59:59  
  X T L Biopharma 2.180 2.410 2.100 +0.190 +9.55% 32.16K 15:59:59  
  Amazon.com 1,632.17 1,681.87 1,610.20 -64.03 -3.77% 6.42M 15:59:59  
  Vale ADR 14.450 14.550 14.315 -0.160 -1.10% 28.37M 15:59:59  
  Tesla 298.92 308.00 295.50 -3.34 -1.10% 12.07M 15:59:59  
  Petroleo Brasileiro Petrobras ADR 15.18 15.46 15.03 -0.22 -1.43% 11.91M 15:59:59  
  Cleveland-Cliffs 8.720 8.880 8.560 -0.290 -3.22% 7.29M 15:59:59  
  Microsoft 105.68 107.10 104.86 -2.03 -1.88% 32.37M 15:59:59  

Trevena Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

51

Equity Type

ORD

Trevena Inc. is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. It is focused on commercializing it in the United States for use in acute care settings, such as hospitals and ambulatory surgery centers. It is also developing TRV250, a G protein biased ligand targeting the o-receptor, as a compound with a non-narcotic mechanism for the treatment of migraine. TRV250 also may have utility in a range of other central nervous system (CNS) indications. It is focused on commencing a Phase I study of TRV250 in the United Kingdom. Its ABLE product platform is a collection of biological information, in vitro assays, know-how and expertise that it uses to identify unique G protein coupled receptors (GPCR)-targeted biased ligands with various pharmaceutical properties.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TRVN Comments

Write your thoughts about Trevena Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kiki Al
Kiki Al Jan 15, 2019 9:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
More than 2.21 this month ✅
Reply
0 0
Kiki Al
Kiki Al Jan 15, 2019 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going up ✅
Reply
0 0
Henry Li
Henry Li Oct 11, 2018 9:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks for posting this
Reply
1 0
Fye Nikka
Fye Nikka Oct 09, 2018 9:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA found that its main drug oliceridine has a high physical dependency risk and is almost certain to be rejected by committee. This is their main DRUG for profit growth...
Reply
6 0
Rajeev Sisodia
Rajeev Sisodia Oct 09, 2018 9:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks for info
Reply
0 0
Kamil Marchwiany
Kamil Marchwiany Oct 09, 2018 9:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Like any other opiate....
Reply
0 0
Justin Campbell
Justin Campbell Oct 09, 2018 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why the premarket tank?
Reply
0 0
Justin Campbell
Justin Campbell Oct 09, 2018 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why the premarket tank?
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email